Last 48 quarters of trend data · Healthcare · Healthcare Software & Telehealth
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.74 | — | — | — | — | — | — | 102.26 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.44 | 0.78 | 1.04 | 0.85 | 0.85 | 1.30 | 2.43 | 0.94 | 0.81 | 1.03 | 1.40 | 2.28 | 1.70 | 1.39 | 0.99 | 0.41 | 0.54 | 0.49 | 0.52 | 0.94 | 0.94 |
| — | -39.9% | -57.1% | -9.7% | +4.7% | +26.0% | +73.8% | -58.7% | -52.1% | -25.9% | +41.9% | +462.1% | +213.1% | +187.6% | +91.0% | -56.6% | -42.5% | -70.8% | -85.1% | -82.4% | -40.9% | |
| P/B Ratio | 3.31 | — | 24.77 | 11.36 | 6.89 | 93.06 | 1581.51 | — | — | — | — | 310.57 | 54.68 | — | — | — | — | 19.77 | 9.22 | 6.66 | 4.00 |
| — | — | -98.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -94.9% | — | |
| P/FCF | — | — | — | 125.85 | — | 12.21 | 13.14 | 308.33 | — | 20.32 | 50.31 | 33.48 | 21.76 | — | 15.11 | — | — | — | — | — | — |
| — | — | — | -59.2% | — | -39.9% | -73.9% | +820.8% | — | — | +232.9% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | 37.86 | 72.42 | 168.05 | 11.47 | 13.95 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | +171.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | 23.46 | 48.86 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.8% | 81.5% | 88.8% | 84.8% | 81.8% | 87.7% | 88.1% | 86.8% | 85.3% | 90.6% | 90.1% | 89.6% | 88.1% | 87.6% | 87.3% | 87.3% | 85.5% | 85.0% | 84.8% | 81.9% | 79.7% |
| — | -7.0% | +0.9% | -2.3% | -4.1% | -3.2% | -2.2% | -3.1% | -3.1% | +3.4% | +3.1% | +2.6% | +3.0% | +3.1% | +3.0% | +6.5% | +7.3% | +6.8% | +4.0% | -0.2% | +15.3% | |
| Operating Margin | -4.0% | -10.0% | -15.1% | -17.8% | -2.3% | -3.3% | -1.5% | 3.9% | 1.6% | -7.5% | -12.4% | -14.0% | -4.8% | -11.8% | -13.6% | -8.6% | -36.9% | -22.5% | -42.4% | -45.1% | -49.8% |
| — | -205.8% | -934.7% | -559.9% | -247.8% | +56.4% | +88.3% | +127.7% | +132.7% | +36.6% | +8.6% | -62.3% | +86.9% | +47.4% | +67.9% | +80.9% | +26.0% | +55.4% | +41.4% | +31.1% | +80.1% | |
| Net Margin | -3.7% | -10.0% | -15.0% | -17.7% | -3.2% | -6.3% | -3.3% | 2.1% | -0.2% | -8.7% | -13.6% | -15.3% | -8.3% | -15.9% | -18.7% | -12.1% | -42.4% | -23.2% | -42.7% | -45.8% | -66.1% |
| — | -58.3% | -349.3% | -939.1% | -1830.8% | +27.7% | +75.4% | +113.7% | +98.0% | +44.9% | +27.5% | -26.7% | +80.4% | +31.6% | +56.2% | +73.6% | +35.7% | +59.7% | +43.3% | +28.2% | +73.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -74.4% | -121.0% | -61.6% | -46.5% | -11.3% | -203.0% | -542.6% | — | — | — | — | -197.2% | -67.0% | — | — | — | — | -147.1% | -112.4% | -63.1% | -324.7% |
| — | +40.4% | +88.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +94.3% | — | |
| ROA | -9.9% | -7.1% | -10.9% | -12.6% | -2.2% | -5.5% | -2.8% | 1.9% | -0.1% | -6.8% | -11.0% | -11.3% | -7.5% | -16.1% | -19.4% | -13.5% | -40.4% | -20.4% | -29.5% | -26.5% | -54.7% |
| — | -29.9% | -286.5% | -766.0% | -1397.1% | +20.1% | +74.3% | +116.8% | +98.1% | +57.5% | +43.5% | +16.2% | +81.4% | +21.2% | +34.1% | +49.3% | +26.0% | +71.3% | +62.5% | +63.2% | +84.0% | |
| ROIC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.27 | — | 0.76 | 0.41 | 0.27 | 1.94 | 57.67 | — | — | — | — | 15.32 | 3.40 | — | — | — | — | 0.46 | 0.23 | 0.11 | 0.07 |
| — | — | -98.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -65.5% | — | |
| Debt / EBITDA | — | — | — | — | 7.42 | 6.38 | 25.10 | 4.83 | 7.04 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | +5.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.25 | 0.80 | 0.90 | 1.04 | 1.25 | 0.73 | 0.77 | 0.82 | 0.81 | 0.83 | 0.87 | 0.99 | 1.22 | 0.77 | 0.64 | 0.71 | 0.36 | 0.52 | 0.72 | 1.15 | 1.97 |
| — | +10.1% | +17.0% | +27.1% | +54.2% | -12.2% | -11.6% | -17.5% | -34.0% | +7.9% | +36.3% | +40.1% | +239.7% | +47.1% | -10.5% | -38.6% | -81.7% | -26.8% | -41.0% | -0.0% | +120.9% | |
| Quick Ratio | 1.18 | 0.63 | 0.84 | 0.98 | 1.18 | 0.66 | 0.72 | 0.77 | 0.76 | 0.78 | 0.83 | 0.94 | 1.15 | 0.65 | 0.52 | 0.58 | 0.24 | 0.37 | 0.60 | 1.11 | 1.90 |
| — | -5.1% | +16.5% | +26.8% | +54.8% | -14.9% | -13.5% | -18.0% | -33.5% | +20.3% | +59.2% | +61.1% | +372.4% | +74.0% | -13.0% | -47.2% | -87.2% | -40.9% | -46.6% | +5.7% | +137.1% | |
| Interest Coverage | -6.48 | -1390.57 | — | — | — | -11.91 | -1.37 | 4.06 | 1.66 | -7.15 | -11.86 | -12.92 | -3.49 | -6.40 | -4.92 | -12.02 | -8.13 | -53.43 | -97.10 | -78.05 | -90.19 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LFMD stock.
LifeMD, Inc.'s current P/E is -3.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
LifeMD, Inc.'s current operating margin is -4.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking LifeMD, Inc.'s business trajectory between earnings reports.